ATHENA: Natural History of Disease Study in Alport Syndrome Patients
NCT02136862
·
clinicaltrials.gov ↗
COMPLETED
Status
165
Enrollment
INDUSTRY
Sponsor class
Conditions
Alport Syndrome Patients With eGFR Between 45-90 ml/Min/1.73 m2
Sponsor
Genzyme, a Sanofi Company